undefined

Jim Doherty

President and Chief Development Officer at Acumen Pharmaceuticals, with a lifelong focus on researching therapeutics for CNS diseases.

Best podcasts with Jim Doherty

Ranked by the Snipd community
undefined
Jan 27, 2025 • 48min

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

Jim Doherty, President and Chief Development Officer at Acumen Pharmaceuticals, shares his extensive experience in developing therapies for CNS diseases. He discusses the historical challenges of Alzheimer’s treatment, the controversies over new amyloid-targeting drugs, and the pivotal role of biomarkers in personalized medicine. Highlighting Acumen's promising candidate, Sobernatug, he reveals its innovative approach to targeting soluble A-beta oligomers, while emphasizing the importance of collaboration and evolving strategies in CNS drug development.